Persistent Dyspnea in Post COVID_19 and Pulmonary Function

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

70 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-04-01

Study Completion Date

2024-04-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

COVID-19 has a high spread rate, millions of people have been infected around the world. Patients complained of different symptoms as fever, dry cough and fatigue which is mild in about 80% of cases, but the severity of the case may progress to develop a respiratory distress or respiratory failure, which may require the need for intensive care unit (ICU)

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Responses to CPET in Subjects With Persistent Exercise Intolerance After COVID-19: an Open-Source Exercise Network

NCT05532995

COVID-19

COMPLETED

COVID-19 Related Lung Ventilation and Perfusion Injury

NCT04549636

Covid-19 Asthma Healthy

COMPLETED

The Long Term Effects of COVID on Pulmonary Function

NCT05077982

Covid19 COVID-19 Pneumonia Critical Illness +1 more

COMPLETED

Late Respiratory Consequences of SARS-CoV-2 Pneumonia

NCT05812196

Respiratory Function Tests Long COVID

RECRUITING

Pulmonary Function in Non-hospitalized Adults and Children After Mild COVID-19

NCT06318208

SARS-CoV-2 Infection

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

COVID-19 has a high spread rate, millions of people have been infected around the world. Patients complained of different symptoms as fever, dry cough and fatigue which is mild in about 80% of cases, but the severity of the case may progress to develop a respiratory distress or respiratory failure, which may require the need for intensive care unit (ICU) Many patients with mild or severe COVID-19 do not make a full recovery and have a wide range of chronic symptoms for weeks or months after infection.

Post-COVID-19 syndrome is defined by persistent clinical signs and symptoms that appear while or after suffering COVID-19, persist for more than 12 weeks and cannot be explained by an alternative diagnosis.

Dyspnea is one of the most prevalent symptoms in post-covid-19 patients in up to 29% of patients with post COVID-19 syndrome.

Also, persistent dyspnea in post COVID-19 infection is frequent, it is so far, of unknown mechanism. Cardiopulmonary Exercise Test (CPET) is currently the gold standard technique in the differential diagnosis of dyspnea.

Cardiopulmonary exercise testing (CPET) is useful in the assessment of subjects with chronic lung conditions as it may help to: 1) recognize physiological factors limiting exercise (with or without the presence of psychogenic limiting factors); 2) identify these factors as potential therapeutic targets; 3) allow quantification of the level of impairment; 4) assess the effects of an intervention; and 5) provide prognostic information.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

covid_19 Patients

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Dyspnea group

Patients with prior diagnosis of COVID-19 and present with persistent dyspnea after 12 weeks of occurrence of symptoms every patient in this group will undergo Cardiopulmonary exercise test (CPET) protocol: -

1. As regard CPET protocol we prepared incremental treadmill exercise protocol in which the work rate increased at one-minute intervals.
2. The following parameters observed:

1. Metabolic response

* Oxygen consumption VO2 (ml/ min):
* P ETO2: Is the end-tidal O2 tension as measured from the exhaled air.
* P ETCO2: Is the end-tidal CO2 tension as measured from the exhaled air. Normally decreased during exercise.
* Anaerobic Threshold (AT): Is defined as the VO2 (in L/min) at which there is substantial transition to anaerobic metabolism to produce extra energy
2. Ventilatory response

* Minute ventilation :
* Breathing reserve(BR): Breathing reserve = measured/predicted minute ventilation maximum
* Tidal volume (VT):
* Respiratory frequency (RF)

cardiopulmonary exercise tests

Intervention Type DIAGNOSTIC_TEST

Spirometry

* forced expiratory volume in 1 second (FEV1) % predicted,
* forced vital capacity (FVC)% predicted,
* forced expiratory volume in 1 second /forced vital capacity FEV1 /FVC

Control group

Patients with prior diagnosis of COVID-19, fully recovered, without persistent dyspnea every patient in this group will undergo Cardiopulmonary exercise test (CPET) protocol: -

1. As regard CPET protocol we prepared incremental treadmill exercise protocol in which the work rate increased at one-minute intervals.
2. The following parameters observed:

1. Metabolic response

* Oxygen consumption VO2 (ml/ min):
* P ETO2: Is the end-tidal O2 tension as measured from the exhaled air.
* P ETCO2: Is the end-tidal CO2 tension as measured from the exhaled air. Normally decreased during exercise.
* Anaerobic Threshold (AT): Is defined as the VO2 (in L/min) at which there is substantial transition to anaerobic metabolism to produce extra energy
2. Ventilatory response

* Minute ventilation :
* Breathing reserve(BR): Breathing reserve = measured/predicted minute ventilation maximum
* Tidal volume (VT):
* Respiratory frequency (RF)

cardiopulmonary exercise tests

Intervention Type DIAGNOSTIC_TEST

Spirometry

* forced expiratory volume in 1 second (FEV1) % predicted,
* forced vital capacity (FVC)% predicted,
* forced expiratory volume in 1 second /forced vital capacity FEV1 /FVC

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

cardiopulmonary exercise tests

Spirometry

* forced expiratory volume in 1 second (FEV1) % predicted,
* forced vital capacity (FVC)% predicted,
* forced expiratory volume in 1 second /forced vital capacity FEV1 /FVC

Intervention Type DIAGNOSTIC_TEST

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

spirometry

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Confirmed or clinically and radiologically highly suspected Covid19-infection
* Symptom duration at least 12 weeks following first occurrence of symptoms
* Patients with dyspnea score 2, 3 and 4 on mMRC
* No other disease that better could explain the symptoms (dyspnea) than Covid-19

Exclusion Criteria

* Age \<18
* pregnant women
* terminally ill patients
* active covid-19 infection
* previous known severe pulmonary or heart disease
* inability to perform pulmonary function or cardiopulmonary exercise tests.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No